Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.59 |
| ▸ | NOX1 | Q9Y5S8 | 7/20 | 0.59 |
| ▸ | MEN1 | O00255 | 6/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.59 |
| ▸ | GAA | P10253 | 6/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | SNCA | P37840 | 7/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29640485 | 1.00 | MAPT (0.59) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL2756476 | 0.92 | NOX1 (0.53) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL239549 | 0.90 | NOX1 (0.65) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL9391898 | 0.88 | SNCA (0.55) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL24255127 | 0.88 | MAPT (0.50) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL17289246 | 0.85 | SNCA (0.83) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL17949769 | 0.85 | MAPT (0.48) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL31538892 | 0.85 | SNCA (0.50) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL9980103 | 0.81 | NOX1 (0.54) | MAPTNOX1MEN1KMT2AGAA | |
| SCHEMBL11381973 | 0.81 | MAOA (0.59) | MAPTNOX1MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117567389-A | Organic photoelectric material and synthesis method and application thereof | 棓诺(苏州)新材料有限公司 | 2024-02-20 | — | — | CN | claimed |
| US-6210536-B1 | DISTILLATION OF ACRYLIC OR METHACRYLIC ACID OR ESTER IN PRESENCE OF POLYMERIZATION INHIBITOR COMPRISING N,N*-DINITROSO PHENYLENEDIAMINE COMPOUND, A HYDROQUINONE OR HYDROQUINONE MONOMETHYL ETHER, PHENYLENEDIAMINE COMPOUND, PHENOTHIAZINE | UNIROYAL CHEMICAL COMPANY, INC. | 2001-04-03 | — | — | US | claimed |
| EP-0522709-B1 | Polymerization inhibitors for acrylic acids and esters | UNIROYAL CHEM CO INC (US) | 1996-08-21 | — | — | EP | claimed |
| EP-0522709-A2 | Polymerization inhibitors for acrylic acids and esters | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1993-01-13 | — | — | EP | claimed |
| EP-0334500-B1 | VINYL AROMATIC COMPOSITONS STABILIZED AGAINST POLYMERIZATION | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1991-06-26 | — | — | EP | claimed |
| US-4915873-A | PHENOTHIAZINE AND ARYL-SUBSTITUTED PHENYLENEDIAMINE | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1990-04-10 | — | — | US | claimed |
| EP-0334500-A1 | Vinyl aromatic compositons stabilized against polymerization | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1989-09-27 | — | — | EP | claimed |
| EP-0325059-A2 | Polymerization inhibitor composition for vinyl aromatic compounds | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1989-07-26 | — | — | EP | claimed |
| US-4363745-A | STERICALLY HINDERED PHENOL, BIS(A,A-DIMETHYLBENZYL) DIPHENYLAMINE AND A PHENOTHIAZINE COMPOUND STABILIZERS | THE DOW CHEMICAL COMPANY (US) | 1982-12-14 | — | — | US | claimed |
| US-4275173-A | SYNERGISTIC COMBINATION OF A STERICALLY HINDERED PHENOL AND 4,4*-BIS/A,A-DIMETHYLBENZYL/DIPHENYL AMINE AND A PHENOTHIAZINE PROVIDE OXIDATION RESISTANCE | THE DOW CHEMICAL COMPANY (US) | 1981-06-23 | — | — | US | claimed |
| US-4265783-A | SYNERGISTIC COMBINATION OF STERIC HINDERED PHENOL, 4,4*-BIS/A,A-DIMETHYL BENZYL/DIPHENYLAMINE AND A PHENOTHIAZINE | THE DOW CHEMICAL COMPANY (US) | 1981-05-05 | — | — | US | claimed |
| US-4010211-A | 2,6-DI-TERT-BUTYL-P-CRESOL, DISUBSTITUTED DIPHENYLAMINE, PHENOTHIAZINE COMPOUND | OLIN CORPORATION (US) | 1977-03-01 | — | — | US | claimed |
| JP-1234405-A | — | — | None | — | — | JP | disclosed |
| EP-4745659-A1 | REFLECTING DEVICE, MANUFACTURING METHOD FOR REFLECTING DEVICE, AND VEHICLE | BYD Company Limited (CN) | 2026-05-20 | — | — | EP | disclosed |
| US-20260103652-A1 | MACROMOLECULAR CORROSION (McIn) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORP (US) | 2026-04-16 | — | — | US | disclosed |
| US-12492352-B2 | Macromolecular corrosion (MCIN) inhibitors: structures, methods of making and using the same | POLNOX CORPORATION (US) | 2025-12-09 | — | — | US | disclosed |
| US-4363745-A | STERICALLY HINDERED PHENOL, BIS(A,A-DIMETHYLBENZYL) DIPHENYLAMINE AND A PHENOTHIAZINE COMPOUND STABILIZERS | THE DOW CHEMICAL COMPANY (US) | 1982-12-14 | — | — | US | disclosed |
| US-4275173-A | SYNERGISTIC COMBINATION OF A STERICALLY HINDERED PHENOL AND 4,4*-BIS/A,A-DIMETHYLBENZYL/DIPHENYL AMINE AND A PHENOTHIAZINE PROVIDE OXIDATION RESISTANCE | THE DOW CHEMICAL COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
| US-4265783-A | SYNERGISTIC COMBINATION OF STERIC HINDERED PHENOL, 4,4*-BIS/A,A-DIMETHYL BENZYL/DIPHENYLAMINE AND A PHENOTHIAZINE | THE DOW CHEMICAL COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| US-4010211-A | 2,6-DI-TERT-BUTYL-P-CRESOL, DISUBSTITUTED DIPHENYLAMINE, PHENOTHIAZINE COMPOUND | OLIN CORPORATION (US) | 1977-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492352-B2 | Macromolecular corrosion (MCIN) inhibitors: structures, methods of making and using the same | MB, NCLN, CPN1 | MAPT 2540/4885NOX1 606/4885MEN1 190/4885 |
| US-20260103652-A1 | MACROMOLECULAR CORROSION (McIn) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | MPO, CYC1, CBR1 | MAPT 4131/4885NOX1 9/4885MEN1 2382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.